BARCLAYS PLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 54 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$3,949
-32.4%
143,463
-16.7%
0.00%
-50.0%
Q2 2023$5,841
+48.9%
172,134
+57.9%
0.00%
+100.0%
Q1 2023$3,922
-24.4%
109,024
-6.4%
0.00%0.0%
Q4 2022$5,191
-99.9%
116,471
-19.4%
0.00%
-50.0%
Q3 2022$4,064,000
+55.2%
144,587
+48.9%
0.00%
+100.0%
Q2 2022$2,618,000
-62.8%
97,087
-53.0%
0.00%
-66.7%
Q1 2022$7,041,000
-34.9%
206,700
-26.2%
0.01%
+200.0%
Q4 2021$10,816,000
+403.8%
279,904
+603.8%
0.00%
+100.0%
Q3 2021$2,147,000
+194.1%
39,768
+82.2%
0.00%
Q2 2021$730,000
-36.0%
21,825
-60.5%
0.00%
-100.0%
Q1 2021$1,140,000
+12566.7%
55,299
+10959.8%
0.00%
Q4 2020$9,000
-30.8%
500
-42.3%
0.00%
Q3 2020$13,000866
+43200.0%
0.00%
Q2 2020$02
-92.3%
0.00%
Q3 2019$0
-100.0%
26
-99.3%
0.00%
Q2 2019$10,000
-77.8%
3,926
-57.0%
0.00%
Q1 2019$45,0009,1260.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,017,524$20,961,0007.56%
Octagon Capital Advisors LP 561,398$11,565,0004.36%
COMMODORE CAPITAL LP 369,951$7,621,0003.04%
Opaleye Management Inc. 985,000$20,291,0002.98%
VR Adviser, LLC 1,240,610$25,557,0002.77%
TSP Capital Management Group, LLC 359,229$7,400,0002.61%
RTW INVESTMENTS, LP 3,908,947$80,524,0001.26%
Ghost Tree Capital, LLC 250,000$5,150,0001.21%
Tri Locum Partners LP 196,672$4,051,0001.00%
Redmile Group, LLC 3,387,788$69,788,0000.98%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders